A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care: Erratum

A new clinical decision support tool for improving the adequacy of anticoagulant therapy and... Medicine Erratum OPEN A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care: Erratum In the article, “A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of [1] stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care”, which appeared in Volume 97, Issue 3 of Medicine, the following funding information should appear: The project was financed in 2016 by the Departament de Salut of the Generalitat de Catalunya (contact information: Travessera de les Corts, 131, 08028 Barcelona), through an external competitive call (Pla estratègic de recerca i innovació en salut (PERIS) - Subvencions per a projectes de recerca orientats a l’atenció primària), grant number SLT002/16/00146. The funder financed the project but will not participate in any phase of the investigation. The funder will not have any authority over any of the activities of the project. Reference [1] Dalmau Llorca MR, Gonçalves AQ, Forcadell Drago E. A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care. Medicine. 97;3:e9578. Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Medicine (2018) 97:6(e9915) http://dx.doi.org/10.1097/MD.0000000000009915 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Medicine Wolters Kluwer Health

A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care: Erratum

Medicine , Volume 97 (6) – Feb 1, 2018
Free
1 page

Loading next page...
1 Page
 
/lp/wolters_kluwer/a-new-clinical-decision-support-tool-for-improving-the-adequacy-of-n1GkWdm6gT
Publisher
Wolters Kluwer
Copyright
Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc.
ISSN
0025-7974
eISSN
1536-5964
D.O.I.
10.1097/MD.0000000000009915
Publisher site
See Article on Publisher Site

Abstract

Medicine Erratum OPEN A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care: Erratum In the article, “A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of [1] stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care”, which appeared in Volume 97, Issue 3 of Medicine, the following funding information should appear: The project was financed in 2016 by the Departament de Salut of the Generalitat de Catalunya (contact information: Travessera de les Corts, 131, 08028 Barcelona), through an external competitive call (Pla estratègic de recerca i innovació en salut (PERIS) - Subvencions per a projectes de recerca orientats a l’atenció primària), grant number SLT002/16/00146. The funder financed the project but will not participate in any phase of the investigation. The funder will not have any authority over any of the activities of the project. Reference [1] Dalmau Llorca MR, Gonçalves AQ, Forcadell Drago E. A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care. Medicine. 97;3:e9578. Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Medicine (2018) 97:6(e9915) http://dx.doi.org/10.1097/MD.0000000000009915

Journal

MedicineWolters Kluwer Health

Published: Feb 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off